Retatrutide 40mg

RET (Retatrutide) 40mg

Form: Lyophilised Powder

Purity: ≥99% (HPLC)

CAS Number: 2381089-83-2

Molecular Weight: 4731.4 g/mol

Vial Size: 3mL

Product Overview

Retatrutide is a triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This higher-dose 40mg formulation is designed for research requiring greater quantities per vial. It represents a next-generation approach to metabolic research with significant interest in weight management and glucose regulation studies. This lyophilised reference material is supplied as a sterile powder in a sealed glass vial.

Key Research Areas

• Triple incretin receptor agonism (GIP/GLP-1/Glucagon)
• Weight management and appetite regulation
• Glucose homeostasis and insulin signalling
• Energy expenditure and metabolic rate
• Multi-receptor peptide pharmacology

Storage

Store in a cool, dry environment protected from light. Refrigerate at 2-8°C after reconstitution with bacteriostatic water and use within 30 days. Freeze at -20°C for extended storage. Avoid repeated freeze-thaw cycles.

⚠️ FOR RESEARCH USE ONLY. This product is not intended for human consumption, therapeutic use, or diagnosis of any kind. It is supplied exclusively for scientific research purposes in controlled laboratory environments.